Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892261432> ?p ?o ?g. }
- W2892261432 endingPage "1572" @default.
- W2892261432 startingPage "1563" @default.
- W2892261432 abstract "Background: Hepatocellular carcinoma (HCC) is the fifth leading cause of cáncer mortality. Elytranthe parasitica (L.) Danser (EP), a hemiparasitic plant (Loranthaceae) has potent anti-cancer properties. Objective: In the study, we investigated the effect of EP fractions on the expression of apoptosis and mitogenactivated protein kinase (MAPK) markers deregulated in HCC. Bioactivity fractionation was performed to isolate the phytochemical(s) exerting anti-tumor activity in HepG2 cells. Method: Anti-proliferative, clonogenic and anti-metastatic effects of EP fractions were examined in hepatocellular carcinoma cell line, HepG2 by Sulphorhodamine B, colony formation and scratch wound assays respectively in hepatocellular cell line, HepG2. The effects of EP fractions on key markers of apoptosis and MAPK signaling pathways were explored. </P><P> Key findings: EP bioactive fractions showed significant anti-tumor potential, reduced clonogenicity and considerably inhibited cell migration in HepG2 cells in vitro. The fractions augmented annexin V binding and induced apoptosis by causing cell cycle arrest at G2/M and S phase checkpoints. The fractions increased expression levels of p53, bad, cleaved PARP (Poly ADP ribose polymerase) and cleaved Caspase-3. Expression levels of phosphorylated ERK1/2 (Extracellular signal-regulated kinase) were downregulated. Pinocembrin-7-O-ß-D-glucoside and chrysin were isolated and characterized for the first time from Elytranthe parasitica (L.) Danser. Conclusion: Our findings reveal that EP fractions induced cell cycle arrest and triggered apoptosis in HepG2 cells by upregulating apoptosis and deactivating MAPK pathway. It signifies that pinocembrin glycoside and chrysin are bioactive phytochemicals contributing to the potent anti-hepatocarcinoma effects on HepG2 cells. Hence, bioactive EP fractions could be used as a therapeutic agent for effective HCC therapy." @default.
- W2892261432 created "2018-09-27" @default.
- W2892261432 creator A5008201728 @default.
- W2892261432 creator A5008991568 @default.
- W2892261432 creator A5015388576 @default.
- W2892261432 creator A5043837644 @default.
- W2892261432 creator A5044049803 @default.
- W2892261432 creator A5051161664 @default.
- W2892261432 creator A5057825310 @default.
- W2892261432 creator A5077584140 @default.
- W2892261432 date "2019-01-28" @default.
- W2892261432 modified "2023-10-16" @default.
- W2892261432 title "Pinocembrin-Enriched Fractions of Elytranthe parasitica (L.) Danser Modulates Apoptotic and MAPK Cellular Signaling in HepG2 Cells" @default.
- W2892261432 cites W1492302205 @default.
- W2892261432 cites W1860682280 @default.
- W2892261432 cites W1871390418 @default.
- W2892261432 cites W1969532763 @default.
- W2892261432 cites W1981332020 @default.
- W2892261432 cites W1981388207 @default.
- W2892261432 cites W1982830461 @default.
- W2892261432 cites W1986735026 @default.
- W2892261432 cites W1988969017 @default.
- W2892261432 cites W1989855597 @default.
- W2892261432 cites W2003278974 @default.
- W2892261432 cites W2004681996 @default.
- W2892261432 cites W2004869810 @default.
- W2892261432 cites W2005236007 @default.
- W2892261432 cites W2005240412 @default.
- W2892261432 cites W2011359957 @default.
- W2892261432 cites W2017168681 @default.
- W2892261432 cites W2019953132 @default.
- W2892261432 cites W2027542963 @default.
- W2892261432 cites W2031823324 @default.
- W2892261432 cites W2033950216 @default.
- W2892261432 cites W2036614475 @default.
- W2892261432 cites W2038264502 @default.
- W2892261432 cites W2043560779 @default.
- W2892261432 cites W2054874597 @default.
- W2892261432 cites W2057713336 @default.
- W2892261432 cites W2058388078 @default.
- W2892261432 cites W2064281953 @default.
- W2892261432 cites W2065171941 @default.
- W2892261432 cites W2074383379 @default.
- W2892261432 cites W2077815748 @default.
- W2892261432 cites W2081145901 @default.
- W2892261432 cites W2087326187 @default.
- W2892261432 cites W2088629624 @default.
- W2892261432 cites W2093628776 @default.
- W2892261432 cites W2095407436 @default.
- W2892261432 cites W2100592123 @default.
- W2892261432 cites W2110523744 @default.
- W2892261432 cites W2119683782 @default.
- W2892261432 cites W2128339707 @default.
- W2892261432 cites W2132834292 @default.
- W2892261432 cites W2133959309 @default.
- W2892261432 cites W2145239509 @default.
- W2892261432 cites W2168242281 @default.
- W2892261432 cites W2168378904 @default.
- W2892261432 cites W2170739098 @default.
- W2892261432 cites W2235472800 @default.
- W2892261432 cites W2294765885 @default.
- W2892261432 cites W2316578968 @default.
- W2892261432 cites W2327833596 @default.
- W2892261432 cites W2340216997 @default.
- W2892261432 cites W2346315096 @default.
- W2892261432 cites W2460832437 @default.
- W2892261432 cites W2473633310 @default.
- W2892261432 cites W2535737599 @default.
- W2892261432 cites W2604407216 @default.
- W2892261432 cites W4245784696 @default.
- W2892261432 doi "https://doi.org/10.2174/1871520618666180911112127" @default.
- W2892261432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30205805" @default.
- W2892261432 hasPublicationYear "2019" @default.
- W2892261432 type Work @default.
- W2892261432 sameAs 2892261432 @default.
- W2892261432 citedByCount "6" @default.
- W2892261432 countsByYear W28922614322019 @default.
- W2892261432 countsByYear W28922614322021 @default.
- W2892261432 countsByYear W28922614322022 @default.
- W2892261432 crossrefType "journal-article" @default.
- W2892261432 hasAuthorship W2892261432A5008201728 @default.
- W2892261432 hasAuthorship W2892261432A5008991568 @default.
- W2892261432 hasAuthorship W2892261432A5015388576 @default.
- W2892261432 hasAuthorship W2892261432A5043837644 @default.
- W2892261432 hasAuthorship W2892261432A5044049803 @default.
- W2892261432 hasAuthorship W2892261432A5051161664 @default.
- W2892261432 hasAuthorship W2892261432A5057825310 @default.
- W2892261432 hasAuthorship W2892261432A5077584140 @default.
- W2892261432 hasConcept C105696609 @default.
- W2892261432 hasConcept C117262875 @default.
- W2892261432 hasConcept C153911025 @default.
- W2892261432 hasConcept C184235292 @default.
- W2892261432 hasConcept C185592680 @default.
- W2892261432 hasConcept C190283241 @default.
- W2892261432 hasConcept C2778004101 @default.
- W2892261432 hasConcept C2779054382 @default.
- W2892261432 hasConcept C2779478871 @default.
- W2892261432 hasConcept C29537977 @default.